Health Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Aethlon Medical, Inc.
Aethlon Medical Announces Expansion Into the Infectious Disease Diagnostic Market
February 27th, 2009
Aethlon Medical, Inc. (OTCBB:AEMD) announced that it has expanded the applications of its Hemopurifier® platform technology to address voids in the infectious disease diagnostic market. The Aethlon Hemopurifier® is a first-in-class artificial adjunct to the immune system able to provide real-time capture of infectious viruses and immunosuppressive particles from the entire circulatory system. The device is a leading broad-spectrum treatment candidate for acute and chronic virus infections. Scientific techniques that established the therapeutic potential of the Hemopurifier® will be leveraged to introduce ultra-sensitive clinical and research diagnostic tools that offer significant...
Source: Health Business Week (2009-02-27)
|
